Skip to content
10-Q

Quarterly Report

SKYSTAR BIO-PHARMACEUTICAL CO

0001144204-14-068847

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 10, 2014 8.7M sh
Shares Diluted Q3 2014 · Sep 30, 2014 8.57M sh
Shares Diluted Q3 2014 · Sep 30, 2014 8.05M sh
Shares Diluted Q3 2014 · Sep 30, 2013 7.62M sh
Shares Diluted Q3 2014 · Sep 30, 2013 7.62M sh
Short Term Debt Q3 2014 · Sep 30, 2014 $19.18M
Short Term Debt Q3 2014 · Sep 30, 2014 ¥118M
Short Term Debt Q3 2014 · Dec 31, 2013 $10.64M
Short Term Debt Q3 2014 · Dec 31, 2013 ¥65M
Cash And Equivalents Q3 2014 · Sep 30, 2014 $14.63M
Cash And Equivalents Q3 2014 · Dec 31, 2013 $8.14M
Cash And Equivalents Q3 2014 · Sep 30, 2013 $4.46M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $11.32M
Stockholders Equity Q3 2014 · Sep 30, 2014 $122.5M
Stockholders Equity Q3 2014 · Dec 31, 2013 $110.39M
Current Liabilities Q3 2014 · Sep 30, 2014 $48.31M
Current Liabilities Q3 2014 · Dec 31, 2013 $25.03M
Total Liabilities Q3 2014 · Sep 30, 2014 $49.1M
Total Liabilities Q3 2014 · Dec 31, 2013 $25.83M
Current Assets Q3 2014 · Sep 30, 2014 $120.86M
Current Assets Q3 2014 · Dec 31, 2013 $88.62M
Total Assets Q3 2014 · Sep 30, 2014 $171.61M
Total Assets Q3 2014 · Dec 31, 2013 $136.22M
Eps Diluted Q3 2014 · Sep 30, 2014 $0.57
Eps Diluted Q3 2014 · Sep 30, 2014 $1.08
Eps Diluted Q3 2014 · Sep 30, 2013 $0.49
Eps Diluted Q3 2014 · Sep 30, 2013 $1.08
Eps Basic Q3 2014 · Sep 30, 2014 $0.58
Eps Basic Q3 2014 · Sep 30, 2014 $1.09
Eps Basic Q3 2014 · Sep 30, 2013 $0.49
Eps Basic Q3 2014 · Sep 30, 2013 $1.08
Sga Expense Q3 2014 · Sep 30, 2014 $1.9M
Sga Expense Q3 2014 · Sep 30, 2014 $4.54M
Sga Expense Q3 2014 · Sep 30, 2013 $1.89M
Sga Expense Q3 2014 · Sep 30, 2013 $3.79M
Rd Expense Q3 2014 · Sep 30, 2014 $378.49K
Rd Expense Q3 2014 · Sep 30, 2014 $1.18M
Rd Expense Q3 2014 · Sep 30, 2013 $324.35K
Rd Expense Q3 2014 · Sep 30, 2013 $417.74K
Net Income Q3 2014 · Sep 30, 2014 $4.91M
Net Income Q3 2014 · Sep 30, 2014 $8.7M
Net Income Q3 2014 · Sep 30, 2013 $3.73M
Net Income Q3 2014 · Sep 30, 2013 $8.2M
Operating Income Q3 2014 · Sep 30, 2014 $5.4M
Operating Income Q3 2014 · Sep 30, 2014 $9.94M
Operating Income Q3 2014 · Sep 30, 2013 $4.74M
Operating Income Q3 2014 · Sep 30, 2013 $10.35M
Gross Profit Q3 2014 · Sep 30, 2014 $8.76M
Gross Profit Q3 2014 · Sep 30, 2014 $17.94M
Gross Profit Q3 2014 · Sep 30, 2013 $8.21M
Gross Profit Q3 2014 · Sep 30, 2013 $16.77M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $9.59M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $21.48M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $7.78M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $16.09M